Copaxone (Teva Neuroscience, Inc.)
Welcome to the PulseAid listing for the Copaxone drug offered from Teva Neuroscience, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Neuroscience, Inc. |
| NON-PROPRIETARY NAME: | Glatiramer Acetate |
| SUBSTANCE NAME: | GLATIRAMER ACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2008-04-28 |
| END MARKETING DATE: | 0000-00-00 |
Copaxone HUMAN PRESCRIPTION DRUG Details:
| Item Description | Copaxone from Teva Neuroscience, Inc. |
| LABELER NAME: | Teva Neuroscience, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2008-04-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68546-317_0f633d13-0640-4aa7-bae8-9b0df8409e12 |
| PRODUCT NDC: | 68546-317 |
| APPLICATION NUMBER: | NDA020622 |
Other GLATIRAMER ACETATE Pharmaceutical Manufacturers / Labelers:
